@Joli_Emile @sebseby @SpellMim @GerardPouzoulet @Maitre_Eolas Autre ref: "Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular disease, or cardiovascular risk factors including noncontrolled diabetes mellitus or arterial hyp
Guidance for the Management of Patients w/ Vascular Disease or Cardiovascular Risk Factors & COVID19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine (2020 Dec) https://t.co/aQCxkTvt3x
RT @GrigorisGerotz1: The "Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19" by VAS…
RT @GBarnesMD: .@AlexSpyropoul cites this excellent graphical review from @TH_Journal about the thrombo-inflammatory mechanist of #COVID19…
RT @GBarnesMD: .@AlexSpyropoul cites this excellent graphical review from @TH_Journal about the thrombo-inflammatory mechanist of #COVID19…
RT @GBarnesMD: .@AlexSpyropoul cites this excellent graphical review from @TH_Journal about the thrombo-inflammatory mechanist of #COVID19…
RT @GBarnesMD: .@AlexSpyropoul cites this excellent graphical review from @TH_Journal about the thrombo-inflammatory mechanist of #COVID19…
.@AlexSpyropoul cites this excellent graphical review from @TH_Journal about the thrombo-inflammatory mechanist of #COVID19 thrombosis at #ISTH2021 https://t.co/zVV34aiJUy https://t.co/F80GjvcIA5
RT @TH_Journal: #December Issue online https://t.co/BTaJlTm0kl #COVID19 Theme Issue On the Cover: Position paper on #Cardiovascular Risk…
#December Issue online https://t.co/BTaJlTm0kl #COVID19 Theme Issue On the Cover: Position paper on #Cardiovascular Risk Factors and COVID-19 by Gerotziafas et al. @GrigorisGerotz1 https://t.co/jhO8y8PjIC
Thieme E-Books & E-Journals - https://t.co/ayOR3UrTbB
My article is featured on the @ResearchGate #COVID19 community page. Read it here: https://t.co/kOUK8RUpRH #WTDay20 #Canvector #EuropeanTHA #ISTH2021 #Cardiotwitter #ZuckerSOM
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
RT @ThiemeNY: October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Man…
October 13 is #WorldThrombosisDay! 💉 On this occasion, we'd like to share a recent position paper on the Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors & #COVID19 with you: Read it for free in @TH_Journal
RT @DucheneJohan: Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19. https://t.co/…
I'm reading https://t.co/wBeuX0h0xN
RT @VACure1: Interesting paper on guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19…
RT @HeleneLBorgne: Certainly relevant not only for @vascern and the whole ERN and rare disease community #ERNeu !
RT @VACure1: Interesting paper on guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19…
Interesting paper on guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19 was published recently, with our project coordinator professor @MiikkaVikkula as a co-author. Read more 👉https://t.co/hZT1VV33om
RT @DucheneJohan: Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19. https://t.co/…
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19. https://t.co/1DFNJr0fyG https://t.co/ejeAHkQtwt
RT @LiverpoolCCS: Helpful guidance here for the management of patients with cardiovascular disease during #COVID19 @TH_Journal @LivHPartners
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
#COVID19 #VTE #thrombosis Which agent? What dose? How long? #MedTwitter #TwitteRx
RT @AlexSpyropoul: Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboproph…
Guidance Statement in management of COVID-19 patients with vascular disease or cardiovascular risk factors: thromboprophylaxis yes, but at what dose intensity? #WTD2020 #isth #ZuckerSOM #Canvector #Cardiotwitter #thrombosis #EuropeanTHA @NATFthrombosis ht
RT @LiverpoolCCS: Helpful guidance here for the management of patients with cardiovascular disease during #COVID19 @TH_Journal @LivHPartner…
Article #freeaccess https://t.co/TKNbdZqh92
RT @LiverpoolCCS: Helpful guidance here for the management of patients with cardiovascular disease during #COVID19 @TH_Journal @LivHPartner…
Helpful guidance here for the management of patients with cardiovascular disease during #COVID19 @TH_Journal @LivHPartners
The "Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19" by VAS-European Independent Foundation in Angiology/ Vascular Medicine are available on line in Thrombosis and Haemostasis. https://t.co/IzmPpA2